The chemical substance known as 4-(((2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl)methyl)-4H-1,2,4-triazole, with the CAS number 2122222-15-3, is a triazole derivative characterized by its unique structural features. This compound contains a triazole ring, which is a five-membered heterocyclic structure containing three nitrogen atoms, contributing to its potential biological activity. The presence of an epoxide group (oxirane) in its structure suggests reactivity, particularly in nucleophilic substitution reactions. The difluorophenyl moiety enhances its lipophilicity and may influence its interaction with biological targets. This compound may exhibit antifungal or antimicrobial properties, typical of many triazole derivatives, due to their ability to inhibit specific enzymes involved in the synthesis of ergosterol, a key component of fungal cell membranes. Additionally, the stereochemistry indicated by the (2R,3S) configuration suggests that the compound may have specific interactions with biological receptors, potentially affecting its pharmacological profile. Overall, this compound's unique structure positions it as a candidate for further investigation in medicinal chemistry.

4-(((2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl)methyl)-4H-1,2,4-triazole

2122222-15-3: The chemical substance known as 4-(((2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl)methyl)-4H-1,2,4-triazole, with the CAS number 2122222-15-3, is a triazole derivative characterized by its unique structural features. This compound contains a triazole ring, which is a five-membered heterocyclic structure containing three nitrogen atoms, contributing to its potential biological activity. The presence of an epoxide group (oxirane) in its structure suggests reactivity, particularly in nucleophilic substitution reactions. The difluorophenyl moiety enhances its lipophilicity and may influence its interaction with biological targets. This compound may exhibit antifungal or antimicrobial properties, typical of many triazole derivatives, due to their ability to inhibit specific enzymes involved in the synthesis of ergosterol, a key component of fungal cell membranes. Additionally, the stereochemistry indicated by the (2R,3S) configuration suggests that the compound may have specific interactions with biological receptors, potentially affecting its pharmacological profile. Overall, this compound's unique structure positions it as a candidate for further investigation in medicinal chemistry.

CAS 2122222-15-3

4-(((2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl)methyl)-4H-1,2,4-triazole

Efinaconazole Impurity 8

Ref: ST-EA-CP-E65025